Skip to main content
APHAmphenol CorporationBuy Wait6.7·$71.64
APH · Why this verdict

Why Amphenol (APH) is rated BUY WAIT

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictBUY WAIT
Overall score6.7/10
ConfidenceMEDIUM
MacroRISK_OFF
TrendMatrix Research · core thesis

Engine thesis — one sentence

Amphenol is a high-quality electronic components maker (ROE 40%, 18% margins) with 65% YoY growth and 20.6% upside to the analyst target, though free cash flow conversion is only 72%, insiders are selling and supply and geographic concentrations are high.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Thesis pillars

Revenue and earnings are growing 65% YoY, scoring 10/10, while the PEG stays at 0.80.

→Stable
Growth breakdown
Expectation
Growth stays above 30% YoY over the next 4 quarters.

CounterGrowth of 65% is hard to sustain on a larger base, and a forward P/E of 22.1x leaves the stock exposed if growth normalizes.

Amphenol earns a 40% return on equity with 18% margins and an 8/9 Piotroski F-Score, but free cash flow is only 72% of net income.

→Stable
Quality breakdown
Expectation
ROE stays above 30% and free cash flow to net income rises toward 90%.

CounterThe 72% cash conversion is flagged as an earnings quality warning and may mean reported profits are not fully backed by cash.

Concentration risks include 65% of exposure in non-U.S. markets and dependence on a single source of supply, with 2 high-severity items.

↓Deteriorating
Bear case
Expectation
No supply interruption and no adverse trade or currency shock over the next 12 months.

CounterA single-source supply disruption or tariff change in foreign markets could hit output and margins quickly.

The $95.61 analyst target is 20.6% above the $79.30 price against 9.9% downside, for a reward-to-risk of 2.08.

↑Improving
Targets
Expectation
Price moves toward $95.61 while holding above the $70.48 stop.

CounterTechnology is a risk-off penalized sector, with a sector modifier of -0.8, so multiple compression could offset earnings growth.

Insiders sold about $69.4M over 90 days with no purchases, while the stock is in an uptrend pullback (RSI 37) above its 200-day average.

↑Improving
Insider
Expectation
The price holds above the 200-day average and insider selling slows.

CounterFive insider sales worth $69.4M signal caution, and a pullback with RSI 37 can extend if sentiment weakens.

Per-dimension breakdown

Value

6.0/10data confidence 100%
ComponentSub-score
P/E3.8
P/S6.3
EV/EBITDA0.6
Fwd P/E5.9
PEG8.2
Analyst target9.0
  • ▸Forward P/E: 21.8x
  • ▸PEG: 0.80

Quality

7.9/10data confidence 100%
ComponentSub-score
ROE10.0
ROA10.0
Gross margin3.8
Op margin10.0
Net margin9.0
Current ratio6.8
FCF quality5.5
Moat6.8
Piotroski F8.9
  • ▸Excellent ROE: 40%
  • ▸Strong margins: 18%
  • ▸Earnings quality warning: 72% FCF/NI
  • ▸Strong Piotroski F-Score: 8/9

Growth

10.0/10data confidence 67%
ComponentSub-score
Rev growth10.0
EPS growth10.0
  • ▸Strong growth: 65% YoY

Momentum

3.1/10data confidence 100%
ComponentSub-score
RSI3.5
MACD0.0
OBV1.0
MA position2.2
Volume8.9
  • ▸Volume distribution (falling OBV)
  • ▸Below 200-MA but MA still rising (+2.6%/30d) — pullback in uptrend, not confirmed weakness

Sentiment

8.1/10data confidence 100%
ComponentSub-score
Analyst rating8.9
Price target9.5
erm sentiment5.0
  • ▸Analyst upside: 49%

Insider

5.1/10data confidence 75%
ComponentSub-score
materiality4.5
holder change5.7
notable moves5.0
  • ▸Modest insider selling — $65,945,990 (0.034% of mkt cap)

Peer rank

5.2/10data confidence 80%
ComponentSub-score
value rank2.9
quality rank9.1
growth rank8.1
  • ▸Superior ROE vs peers
  • ▸Best-in-class margins

Technical

8.2/10data confidence 100%
ComponentSub-score
bollinger9.9
support resistance9.8
52w position5.9
gap7.0

Risk (lower is worse)

4.7/10data confidence 100%
ComponentSub-score
short interest9.4
days to cover8.6
volatility0.0
put call3.0
implied vol1.1
beta5.9
debt equity4.9
  • ▸Elevated put/call: 1.54
  • ▸High IV: 73%
  • ▸Concentration risks: 2 HIGH, 1 MED (10-K Item 1A — sized via position_sizing, validated via buy_confidence)

Catalyst

6.8/10data confidence 100%
ComponentSub-score
erm5.0
earnings history10.0
earnings timing5.0
surprise avg7.2
dividend safety6.8
  • ▸Perfect beat streak: 4Q

How the verdict was assembled

Engine trigger

Growth is cheap relative to earnings, but the technical setup has not yet produced a breakout above resistance (PEG 0.80, quality 7.9/10, growth 10.0/10).

Engine technical detail
verdict_path: L4:PATH_C2_GARP_WAIT|ENTRY_STICKY:WITHIN_BAND
Passed (7)
  • ASYMMETRY:2.8>=1.5
  • INSIDER:OK
  • 8K:CLEAN
  • NEWS_EVENTS:NONE_RECENT
  • EARNINGS_PROXIMITY:83d clear
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
  • MOMENTUM:3.1<4.5
Warning (0)

none

Reward-to-Risk
2.83
Upside
+34.4%
Downside
12.2%
Sizing output
STARTER

Setup— — No clear chart pattern; technical signals are mixed

EdgeTemporary headwind — High quality (7.9) with weak momentum (3.1)

SuitabilityModerate — Balanced profile

Investment implication

The C-path quality+growth combination triggered the STRONG_BUY_WAIT verdict: quality 7.9 and growth 10.0 both clear their thresholds, with asymmetric R:R of 2.83 supporting the read.

The strongest dimensions are Growth at 10.0, Technical at 8.2, and Sentiment at 8.1; the weakest are Momentum at 3.1, Risk (lower is worse) at 4.7, and Insider at 5.1. The V9 engine flagged 1 failed gate, producing an asymmetric reward-to-risk of 2.83 and an engine sizing output of STARTER.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Explosive Growth Reasonable Peg

    Trip ifRevenue growth falls below 20% YoY for 2 consecutive quarters.

  • P2High Returns And Margins

    Trip ifFree cash flow to net income falls below 60%.

  • P3Analyst Upside To Target

    Trip ifPrice falls below the $70.48 stop level.

  • P4Supplier And Geographic Concentration

    Trip ifAny single-source supply disruption lasting more than 1 quarter reduces revenue by more than 5%.

  • P5Insider Selling Uptrend Pullback

    Trip ifNet insider selling exceeds $150M over a 90-day period.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home › Stocks › APH › Why this verdict